DUBLIN--(BUSINESS WIRE)--Sep 12, 2022--
The "China Percutaneous Coronary Interventions Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook" report has been added to ResearchAndMarkets.com's offering.
Why Buy This Report
- First-ever syndicated report with robust insights from Interventional Cardiologists and Cardiologists
- Helps in understanding the current market scenario of the percutaneous coronary interventions in China
- Includes 100+ slide MS PowerPoint report and a MS Excel based 5-year market forecast model
- Valuable insights from demand side of the market
- Keep up with the latest market trends and novel technologies
Identify key players, local players and emerging players in the market
- Boston Scientific
- Medtronic
- Cordis
- B.Braun
- Shockwave Medical
- Philips
- Terumo
- BD/Bard
- Concept Medical
- OrbusNeich
- Microport Scientific
- JW Medical
- Genoss
- Shanghai Bio-heart biological Technology Co
- Elixir Medical Corporation
- Abbott
- Sinomed
- Kossel MedTech
- Biosensors International
- Lepu Medical
- LifeTech Scientific
Key Topics Covered:
RESEARCH PROCESS OVERVIEW
- Detailed Research Methodology
- Desk Research and Quantitative Research
EXECUTIVE SUMMARY
PERCUTANEOUS CORONARY INTERVENTION (PCI) CHINA MARKET OVERVIEW
- Market Background - What is the scope of the research?
I - HEALTHCARE INFRASTRUCTURE (PROVIDER)
- Healthcare Delivery Structure
- Cardiac Catheterization and Chest Pain Centres (CPC) in China
- Chest Pain Centers (CPC) - Impact on Diagnosis and Treatment
- Healthcare Infrastructure - Digital Health Technology (DHT)
- Healthcare Infrastructure Challenges
- Percutaneous Coronary Intervention - Access Point
II - PROCEDURE INSIGHTS
- Procedure Split by Facility Type
- Procedure Split by Imaging Type
- Procedure Split by Device Type
- Procedure Split by Techniques
- Procedure Split by Intervention Type
- Procedure Growth Rates
III - BRAND PERCEPTION
- Brand Perception (Interventionalists)
- Best-in-Class Brands
IV - COMPETITIVE INTELLIGENCE
- CI Snapshot
- Key Competitor Activities
- Product portfolio
- Product Approval Overview
- Clinical Trials Overview
- Company Profile
- Product Approvals
- Clinical Trials
- Partnerships, M&A, Collaborations
- Key Market Activities
- Major Adverse Events
V - HEALTHCARE POLICY (PAYER)
- Medical Devices Regulatory Body
- Regulatory Approval Pathway
- Reimbursement landscape
- Disease Screening and Awareness Programs
- Health Insurance Coverage
- Digital Health Policy
VI - CLINICAL INTELLIGENCE (PHYSICIAN)
- Referral Pathway
- Treatment Overview
- Treatment Care Pathway
- Interventional Therapies
- Interventional Technology
- Healthcare Specialists (who are the Performing Physicians)
- Epidemiology
CONCLUSION
APPENDICES
For more information about this report visit https://www.researchandmarkets.com/r/kd6x51.
View source version on businesswire.com:https://www.businesswire.com/news/home/20220912005869/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: CHINA ASIA PACIFIC
